M, R., D, X., Y, L., Y, F., & J, X. (2020). Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China. Journal of medical economics, 23(4), 394. https://doi.org/10.1080/13696998.2019.1699799
Chicago Style (17th ed.) CitationM, Ren, Xuan D, Lu Y, Fu Y, and Xuan J. "Economic Evaluation of Olmesartan/amlodipine Fixed-dose Combination for Hypertension Treatment in China." Journal of Medical Economics 23, no. 4 (2020): 394. https://doi.org/10.1080/13696998.2019.1699799.
MLA (9th ed.) CitationM, Ren, et al. "Economic Evaluation of Olmesartan/amlodipine Fixed-dose Combination for Hypertension Treatment in China." Journal of Medical Economics, vol. 23, no. 4, 2020, p. 394, https://doi.org/10.1080/13696998.2019.1699799.